For the past week, the FDA has been on hold. At the end of 2016, the agency had over 700 vacant positions in its drug department, and more to come with the 21st Century Care Act. The hiring freeze is stopping the agency from working within its usual restricted timeframes. Drug approvals are slowing due to lack of resources, and these slowed approvals, officials say, could raise drug prices in 2017. Read the full article here.